The Quality unit conducts the risk assessment of the quality module (part 3) of the dossier of conventional (chemical) medicinal products, both human and veterinary, and human biological medicinal products. Employees (assessors, mostly pharmacists, chemists and biologists) work at the national and international (EMA, EDQM, ICH and WHO) level on behalf of the MEB to incorporate new developments and insights in the area of quality of medicinal products and raw materials in a regulatory setting into guidelines, assessments and scientific recommendations.

Head of unit

Mrs. Nanneke (N.) Hendricks